Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CREBBP | Q92793 | 20/20 | 0.67 |
| ▸ | BRD4 | O60885 | 16/20 | 0.67 |
| ▸ | EP300 | Q09472 | 2/20 | 0.67 |
| ▸ | CECR2 | Q9BXF3 | 1/20 | 0.67 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31565594 | 0.87 | CREBBP (0.77) | CREBBPBRD4EP300CECR2BRD9 | |
| SCHEMBL31496068 | 0.83 | CREBBP (0.64) | CREBBPBRD4EP300CECR2BRD9 | |
| SCHEMBL17673230 | 0.81 | CREBBP (1.00) | CREBBPBRD4EP300CECR2BRD9 | |
| SCHEMBL36069591 | 0.81 | CREBBP (1.00) | CREBBPBRD4EP300CECR2BRD9 | |
| SCHEMBL17673292 | 0.79 | CREBBP (0.79) | CREBBPBRD4EP300CECR2BRD9 | |
| SCHEMBL31496244 | 0.78 | CREBBP (0.62) | CREBBPBRD4EP300CECR2BRD9 | |
| SCHEMBL31565579 | 0.77 | GPR119 (0.48) | — | |
| SCHEMBL17673139 | 0.74 | CREBBP (0.74) | CREBBPBRD4EP300CECR2BRD9 | |
| SCHEMBL25049619 | 0.74 | CREBBP (0.84) | CREBBPBRD4EP300CECR2BRD9 | |
| SCHEMBL17680878 | 0.72 | CREBBP (0.81) | CREBBPBRD4EP300CECR2BRD9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129070-A1 | BIFUNCTIONAL ANDROGEN RECEPTOR COMPOUNDS | KOLM THERAPEUTICS INC. | 2025-04-24 | — | — | US | disclosed |
| WO-2025081082-A1 | BIFUNCTIONAL ANDROGEN RECEPTOR COMPOUNDS | KOLM THERAPEUTICS INC. (US) | 2025-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129070-A1 | BIFUNCTIONAL ANDROGEN RECEPTOR COMPOUNDS | AR, SHBG, FSHR | CREBBP 2932/4885BRD4 674/4885EP300 1000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.